Seaforth Energy Inc. Announces Italian Business Expansion

Seaforth Energy Inc. announces the expansion of its Italian business with their distribution partner Fenyx. Fenyx has deployed two AOCs in Italy already and now has placed a further order for four additional AOC 15/50s for its clients.

“The AOC 15/50 is a proven wind turbine and its dependability and durability are critical for our customers,” said Andrea Toma, manager for Fenyx in Italy. “Its global deployments and 15+ year track record of certified power production make it an excellent solution for our clients and agents in Italy.”

Seaforth Energy Inc. Secures $2 Million Financing

Seaforth Energy Inc., a leading wind turbine manufacturer and renewable energy integrator, has secured $2 million in financing from Innovacorp, the Business Development Bank of Canada (BDC), Seaforth Engineering Group, and private investors.

The funds will be used to accelerate the company's export growth in new markets and scale up operations as it delivers on its committed backlog of orders.

e-academy CEO Appointed to Telefilm Canada

The Honourable James Moore, Minister of Canadian Heritage and Official Languages, today announced the appointment of Ram Krishna Raju as a member of Telefilm Canada.

"I am delighted that Mr. Raju has accepted this appointment," said Minister Moore. "Telefilm Canada will undoubtedly benefit from his strong leadership, dynamism, extensive knowledge, and experience in the digital and information technology industry."

Call for Applications - Innovacorp Board Members

Innovacorp helps high potential early stage Nova Scotia companies commercialize their technologies and succeed in the global marketplace. Our High Performance Incubation (HPi)™ business model incorporates incubation infrastructure, business mentoring, and seed and venture capital investment. HPi is recognized internationally as a best practice technology commercialization approach.

Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute

Immunovaccine Inc.(TSX-V:IMV), a vaccine development company, announced today that it has signed a collaborative agreement with the Dana-Farber Cancer Institute, a principal teaching affiliate of the Harvard Medical School.

The research collaboration involves formulating Dana-Farber’s HIV protein antigens in Immunovaccine’s DepoVax™ vaccine enhancement and delivery platform. The goal of this preclinical research is to establish whether this novel vaccine formulation will induce a stronger immune response.

Innovacorp Finalist for International Business Incubation Award

Innovacorp has once again been named one of two finalists in the National Business Incubation Association (NBIA) Incubation Program of the Year - 2010 competition.

The award recognizes the world's best methods to help new companies commercialize innovations and overcome hurdles to business growth. Innovacorp is a finalist alongside Emerging Technology Centers in Baltimore, Maryland.


Subscribe to Innovacorp RSS